TCM Limited (BOM:524156)

Achilles Therapeutics Statistics

Total Valuation

TCM Limited has a market cap or net worth of INR 291.41 million. The enterprise value is 386.47 million.

Market Cap	291.41M
Enterprise Value	386.47M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TCM Limited has 7.48 million shares outstanding. The number of shares has increased by 11.26% in one year.

Current Share Class	7.48M
Shares Outstanding	7.48M
Shares Change (YoY)	+11.26%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	63.55%
Owned by Institutions (%)	9.21%
Float	2.73M

Valuation Ratios

The trailing PE ratio is 18.04.

PE Ratio	18.04
Forward PE	n/a
PS Ratio	1.12
PB Ratio	1.00
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	23.98
EV / Sales	1.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.65

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.38.

Current Ratio	1.30
Quick Ratio	0.15
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	-1.06
Interest Coverage	-4.26

Financial Efficiency

Return on equity (ROE) is 4.92% and return on invested capital (ROIC) is -4.59%.

Return on Equity (ROE)	4.92%
Return on Assets (ROA)	-1.96%
Return on Invested Capital (ROIC)	-4.59%
Return on Capital Employed (ROCE)	-8.52%
Revenue Per Employee	4.00M
Profits Per Employee	247,969
Employee Count	65
Asset Turnover	0.32
Inventory Turnover	0.62

Taxes

Income Tax	-340,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.85% in the last 52 weeks. The beta is -0.16, so TCM Limited's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	-16.85%
50-Day Moving Average	40.85
200-Day Moving Average	44.78
Relative Strength Index (RSI)	42.32
Average Volume (20 Days)	3,573

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TCM Limited had revenue of INR 260.06 million and earned 16.12 million in profits. Earnings per share was 2.16.

Revenue	260.06M
Gross Profit	78.23M
Operating Income	-25.13M
Pretax Income	13.65M
Net Income	16.12M
EBITDA	-21.62M
EBIT	-25.13M
Earnings Per Share (EPS)	2.16

Balance Sheet

The company has 4.09 million in cash and 112.24 million in debt, giving a net cash position of -108.15 million or -14.46 per share.

Cash & Cash Equivalents	4.09M
Total Debt	112.24M
Net Cash	-108.15M
Net Cash Per Share	-14.46
Equity (Book Value)	292.07M
Book Value Per Share	40.81
Working Capital	140.44M

Cash Flow

In the last 12 months, operating cash flow was -100.78 million and capital expenditures -5.23 million, giving a free cash flow of -106.01 million.

Operating Cash Flow	-100.78M
Capital Expenditures	-5.23M
Free Cash Flow	-106.01M
FCF Per Share	-14.18

Margins

Gross margin is 30.08%, with operating and profit margins of -9.66% and 6.20%.

Gross Margin	30.08%
Operating Margin	-9.66%
Pretax Margin	5.25%
Profit Margin	6.20%
EBITDA Margin	-8.31%
EBIT Margin	-9.66%
FCF Margin	n/a

Dividends & Yields

TCM Limited does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.26%
Shareholder Yield	n/a
Earnings Yield	5.53%
FCF Yield	-36.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4